(Q40894870)

24 September 2017

title

HPV type 16 protein E7 HLA-A2 binding peptides are immunogenic but not processed and presented (English)

1 reference

24 September 2017

Bauer M

1

1 reference

24 September 2017

Wagner H

series ordinal

2

1 reference

24 September 2017

Lipford GB

series ordinal

3

1 reference

24 September 2017

publication date

1 January 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

71

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

55-59

1 reference

Human papillomaviruses in the pathogenesis of anogenital cancer

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Cytotoxic T cells recognize fragments of the influenza nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

HLA-A2-restricted peripheral blood cytolytic T lymphocyte response to HPV type 16 proteins E6 and E7 from patients with neoplastic cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Peptide-induced stabilization and intracellular localization of empty HLA class I complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2899%2900170-4

7 January 2021

10.1016/S0165-2478(99)00170-4

Identifiers

DOI

1 reference

24 September 2017

1 reference